SEC Form 4 · accession 0001513162-18-000233
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Kumar
Officer — Chief Executive Officer · Director
Period of report
Sep 13, 2018
Accepted (ET)
Sep 14, 2018 · 9:54 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 13, 2018 | P | 3,000 | $3.84 | A | 136,000 | D |
Table II — derivative securities
No Table II lines on this filing.